In the GxE interaction study, the estimated statistical power was 96.1% for SELENOP rs3877899GA+AA genotypes and 99.9% for ELGA in the analysis of the proliferative type of ROP (requiring treatment). The gene discussed is SELENOP; the disease is retinopathy of prematurity.